# Scoping Analysis: LLM, AI, and Agentic AI in International Outbreak Monitoring

## Literature Review 2022–2026 | Event-Based Surveillance Focus

### Version 4.0 — Updated with 2026 Developments + Personal Annotation System

---

## Document Information

| Field | Detail |
|-------|--------|
| **Document version** | 4.0 (Updated with 2026 literature) |
| **Date compiled** | May 13, 2026 |
| **Scope** | Literature 2022–2026 (May), focus on event-based surveillance (EBS) |
| **Geographic coverage** | Global, with regional case studies |
| **Audience** | Public health epidemiologists, data scientists, policymakers |
| **Owner** | Kai (personal scoping analysis) |

---
## 📝 HOW TO USE THIS DOCUMENT — PERSONAL ANNOTATION GUIDE

This document is designed for you to add personal notes that are clearly distinguishable from the AI-generated content. **Recommended annotation system:**

### Annotation Conventions

Use the following markdown patterns to mark your personal comments. They render cleanly in any markdown viewer (GitHub, Obsidian, Notion, VS Code) and are visually distinct:

| Annotation Type | Format | When to Use |
|-----------------|--------|-------------|
| **Personal note** | `> 💭 **[KAI]:** Your comment here` | General reflections, opinions, agreement/disagreement |
| **Key insight for writing** | `> ✍️ **[KAI–WRITING]:** Your comment here` | Material to use in manuscripts or papers |
| **Key insight for presentation** | `> 🎤 **[KAI–PRESENTATION]:** Your comment here` | Material for slide decks, talks |
| **Question / to verify** | `> ❓ **[KAI–CHECK]:** Your comment here` | Items to verify, follow up, or fact-check |
| **Disagreement / critique** | `> ⚠️ **[KAI–CRITIQUE]:** Your comment here` | Where you disagree with the source or analysis |
| **Cross-reference** | `> 🔗 **[KAI–LINK]:** Compare with [other paper] because...` | Connections to other literature you've read |
| **Action item** | `> ✅ **[KAI–TODO]:** Action item` | Tasks (e.g., read full paper, contact author) |
| **Quote to remember** | `> 💬 **[KAI–QUOTE]:** "..." — source` | Direct quotes you want to cite verbatim |


---

## Executive Summary

This scoping analysis synthesizes developments from **2022 through May 2026** in the application of Large Language Models (LLMs), artificial intelligence (AI), and agentic AI systems to international outbreak and epidemic monitoring with a focus on **event-based surveillance (EBS)**. Key findings:

1. **Current Development State (2026)**: LLMs have transitioned from prototypes to operational global infrastructure. **BEACON** (launched April 2025 at Boston University) represents the first generative-AI native EBS platform, using a domain-adapted **PandemIQ Llama LLM**. EIOS now supports **110+ countries and 30+ organizations** (up from ~70 countries in 2024). The WHO Hub worked with **160+ Member States and 190+ partners** in 2025.

2. **Deployment Landscape**: Nine major operational systems globally — EPIWATCH (UNSW), EIOS (WHO/JRC), HealthMap, ProMED-mail, BlueDot, Epitweetr (ECDC), Metabiota, CDC's GBSP, and **BEACON (NEW, 2025)**. Agentic AI is now operational (ARIES, BEACON's multi-agent LLM architecture), not aspirational.

3. **Documented Early Detection**: HealthMap flagged COVID-19 cluster on Dec 30, 2019; EPIWATCH would have detected Ebola signals months ahead in West Africa 2013 and severe pneumonia in Hubei in November 2019.

4. **2026 Institutional Developments**: WHO launched **All-Hazards Information Management (AIM) Toolkit**; Eastern Mediterranean WHO Office established **AI Community of Practice for Disaster Surveillance** (April 2026); WHO Hub launched **Pandemic and Epidemic Intelligence Research Funding Tracker**; World Economic Forum announced **Pandemic Preparedness Engine (PPX)** and **Global Pathogen Analysis Platform (GPAP)** at 2026 Annual Meeting.

5. **Persistent Challenges**: Data quality, algorithmic bias, integration with traditional surveillance, privacy, misinformation/stigma amplification, LLM hallucinations, and a new 2026 concern — **AI-generated misinformation indistinguishable from human content** complicates surveillance signal validation.

6. **Future Outlook**: One Health integration (human-animal-plant-environment); multimodal LLMs; federated learning; AI literacy mainstreaming via WHO AI Literacy Programme; democratization through open-source platforms (BEACON); and collaborative international networks.
> 💭 **[KAI]:** why beacon is a open source platform, what does that mean?
---

## 🆕 2026 KEY DEVELOPMENTS — NEW SECTION

This section highlights what is NEW in the field as of May 2026, compared to 2022–2025 baseline.

### 1. BEACON Platform Launch (April 2025) — First Generative-AI Native EBS

**The Biothreats Emergence, Analysis and Communications Network (BEACON)** is a paradigm-shifting open-source EBS platform that became operational in mid-2025 and was formally described in *Journal of Infectious Diseases* (Feb 2026).

| Feature | Detail |
|---------|--------|
| **Organization** | Boston University Center on Emerging Infectious Diseases + Hariri Institute + HealthMap (Boston Children's) |
| **Director** | Dr. Nahid Bhadelia (former White House COVID-19 response team, 2022–2023) |
| **AI Architecture** | **PandemIQ Llama LLM** — fine-tuned foundational LLM on medical literature, historical outbreak data, iterative SME feedback |
| **Multi-Agent Design** | LLM powers multiple AI agents with custom-engineered prompts incorporating SME decision-making processes |
| **Data Source** | HealthMap (hourly scrapes, **17 languages**), global analyst staff, public health partners, direct user submissions |
| **Key Function** | Extracts info; evaluates source credibility, recency, severity, urgency; drafts initial reports |
| **Funding** | $6 million — NSF, Gates Foundation, private donors, Boston University |
| **Partners** | WHO EIOS, World Organisation for Animal Health (WOAH), CEPI, state health depts, CDC Center for Forecasting and Outbreak Analytics |
| **Status** | **Beta launched April 2025**; first peer-reviewed publication Feb 2026 |
| **Innovation** | First biothreats reporting system to use **generative AI** (vs. earlier BERT classification); multi-agent architecture; freely accessible |

**Reference**: BEACON Team. "A BEACON for Novel Disease Threats: Leveraging AI for Informal Event-Based Outbreak Surveillance." *J Infect Dis*. 2026;233(2):e287. DOI: 10.1093/infdis/jiaf642

**URL**: https://academic.oup.com/jid/article/233/2/e287/8407011

> 💭 **[KAI]:** _Add your note here..._

---

### 2. WHO EIOS Expansion (2026 update)

WHO Director-General announced at the 158th Executive Board session (Feb 2, 2026):

> "The WHO Hub for Pandemic and Epidemic Intelligence launched an update of the Epidemic Intelligence from Open Sources system – EIOS – which harnesses the power of AI to support more than **110 countries and 30 organizations**."

**Other 2026 WHO data points:**
- GISRS processed **12+ million samples** in 2025
- PIP Framework: 8 new agreements giving access to **900+ million vaccine doses** for pandemic influenza
- WHO Hub in Berlin worked with **160+ Member States and 190+ partners** in 2025

**Reference**: WHO Director-General opening remarks, 158th Executive Board session, Feb 2, 2026.
**URL**: https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-158th-session-of-the-executive-board-2-february-2026

> 💭 **[KAI]:** important

---

### 3. WHO All-Hazards Information Management (AIM) Toolkit (2025–2026)

- **Launched**: 2025 by WHO Hub for Pandemic and Epidemic Intelligence
- **Purpose**: AI-powered solution for emergency information management
- **Outputs**: Rapid risk assessments, response plans, monitoring tools, situation reports
- **Training**: 20 countries trained in AIM Toolkit use plus AI literacy for emergency preparedness/surveillance
- **Quote**: "AI has enormous potential in public health, but its impact depends on how responsibly and effectively it is applied." — Dr Oliver Morgan, Head of WHO Hub for Pandemic and Epidemic Intelligence

**Reference**: WHO Eastern Mediterranean Regional Office announcement, April 16, 2026.
**URL**: https://www.emro.who.int/media/news/who-regional-office-for-the-eastern-mediterranean-launches-ai-community-of-practice-for-disaster-and-emergency-response-surveillance.html

> 💭 **[KAI]:** not mature

---

### 4. WHO AI Community of Practice — Eastern Mediterranean (April 2026)

- **Launched**: April 16, 2026
- **Platform**: WHO Collaboratory
- **Purpose**: Strengthen national/regional capacity to evaluate, adopt, govern, scale AI tools safely, ethically, effectively during disasters and health emergencies
- **Components**: Curated training modules, peer-to-peer learning, technical working groups, repository of best practices
- **Position**: Core component of **WHO AI Literacy Programme**

> 💭 **[KAI]:** not important

---



---

### 6. World Economic Forum — Two New Global Platforms (Jan 2026)

Announced at WEF Annual Meeting 2026 as global public goods:

| Platform | Function |
|----------|----------|
| **Pandemic Preparedness Engine (PPX)** | End-to-end R&D platform integrating genomic surveillance + epidemiological modeling + viral evolution + antigen design via agentic AI |
| **Global Pathogen Analysis Platform (GPAP)** | World's first globally accessible, AI-powered platform turning pathogen data (human, animal, plant, environmental — **One Health**) into standardized, actionable intelligence |

**Partners**: WEF + CEPI (Coalition for Epidemic Preparedness Innovations)

**Reference**: World Economic Forum, "How AI reshapes global preparedness for infectious disease," Jan 23, 2026.
**URL**: https://www.weforum.org/stories/2026/01/ai-global-preparedness-infectious-disease/

> 💭 **[KAI]:** promising
---

### 7. AI Agents for Respiratory Diseases — Quadripartite Framework (2026 peer-reviewed)

The Yang et al. 2026 paper in JMIR formalizes the **quadripartite framework**:

1. Surveillance
2. Risk evaluation
3. Early warning
4. **Decision support and intervention optimization through AI agents** ← NEW PILLAR

**Application example**: Given an emerging RSV outbreak in a region with limited ICU capacity, AI agents synthesize epidemiological forecasts, resource availability, and intervention effectiveness data to recommend optimal response strategies.

**Reference**: Yang L, Shan L, Cao X, Cui J, Tong M, Niu Y, Zhang T. AI Agents and Epidemic Intelligence on Respiratory Infectious Diseases: Toward a Conceptual Framework Integrating Decision Support. *J Med Internet Res.* 2026;28:e86936. DOI: 10.2196/86936
**URL**: https://www.jmir.org/2026/1/e86936

> 💭 **[KAI]:** relevant. universal epidemic intelligence model. only single country implementation

---

### 8. ARIES Agentic Framework Formalized (Jan 2026)

The ARIES framework received expanded formalization in early 2026:

- Components: Flows, Crews, Agents, Process, Tasks
- Configurable: Memory, LLMs, Knowledge, Reasoning, Training, Tools
- Inspired by Sara De Luca's zero-shot LLM classification (90.2% precision) on COVID-19 (2020–2022) and Mpox (Europe)
- **Goal**: Decision Intelligence System reducing hallucination, retrieving updated information only, task-specific

**Reference**: Wattamwar A, Akwafuo S. ARIES: A Scalable Multi-Agent Orchestration Framework. *arXiv* 2601.01831, January 2026.  https://arxiv.org/pdf/2601.01831

> 💭 **[KAI]:** manager agent + Sepcialized agents (A layer of sub-agents, each assigned a domain-specific
persona and toolset: Senior Medical Scientist, CDC Data Analyst, WHOIntelligence Officer ). a Hierarchical Multi-Agent Architecture is not only capable of replicating the investigative workflows of a human epidemiologist but can do so with a level of speed and cross-source verification that exceeds manual capabilities. 
Future roadmap: MCP, Agentic Self-Correction, Integration of Unconventional Data Streams, Weeky Epidemiological Records

### 8-2. Why can’t epidemiology be automated (yet)? Perhaps it shouldn’t be Roemer J. Janse 1,2, and Amber Meulenbeld
International Journal of Epidemiology, 2026, 55(3), dyag065 
https://doi.org/10.1093/ije/dyag065 


---

### 9. Generative AI Risk to Surveillance Validity (2026 concern)

**Emerging meta-challenge**: AI-generated misinformation now indistinguishable from human-written content.

- Traditional fraud/misinformation detection relied on linguistic red flags (awkward phrasing, grammatical errors)
- These signals are **now gone** with GPT-class models
- Direct implication for surveillance: **AI-fabricated outbreak reports** could enter EBS pipelines undetected
- Need: New verification frameworks (cryptographic signing, source-chain provenance, multi-source corroboration)

**Source**: Multiple 2026 reports on AI-driven content (referenced in journalism/security literature)

> 💭 **[KAI]:** reference unknonwn

---

### 10. ChatGPT-Assisted Deep Learning for ILI Prediction (China, 2025–2026)

- 5 deep learning architectures (LSTM, N-BEATS, transformer, TFT, TiDE) developed via **ChatGPT-assisted workflow** (code gen, debugging, optimization)
- Trained 2014–2023, tested 2024 holdout
- Demonstrates **ChatGPT as research accelerator** for traditional epi modeling — not just for text extraction
- Practical lesson: LLMs lower the barrier to deep learning model development for epidemiologists

**Reference**: Huang W et al. ChatGPT-Assisted Deep Learning Models for Influenza-Like Illness Prediction in Mainland China. 2025. DOI: 10.2196/74423

> 💭 **[KAI]:** prediction usage

---

### 11. Koopmans 2026 Comment — Critical View on "Black Box" AI

In a Medscape commentary (Jan 14, 2026), Prof. Marion Koopmans argued:

- AI + One Health approach could strengthen pandemic preparedness by identifying areas needing greater surveillance
- **BUT**: as AI-generated outputs become indistinguishable from human analysis, reliability/accuracy assessment becomes critical
- Urged skepticism toward "black box" solutions
- AI tools should be evaluated with the same rigor applied to new diagnostics

**Reference**: Could Artificial Intelligence Help Predict the Next Pandemic? Medscape, Jan 14, 2026.

> 💭 **[KAI]:** this is a concern topic
---

## 1. Scope and Definitions

### 1.2 Methodology

Literature search across PubMed, ScienceDirect, Frontiers, arXiv, biorXiv, WHO publications, JMIR, JID, and grey literature for studies and operational reports published **2022–May 2026** focusing on AI/LLM/agentic AI applications in epidemic intelligence and EBS.

---

## REFERENCE TABLE 1: Foundation & Current Development (Updated)

| Title | Link | Year | Key Finding | Relevance | KAI Notes |
|-------|------|------|-------------|-----------|-----------|
| **Preventing the next pandemic: Use of artificial intelligence for epidemic monitoring and alerts** (MacIntyre et al., Cell Reports Medicine) | https://doi.org/10.1016/j.xcrm.2022.100867 | 2022 | EPIWATCH origin paper. Demonstrates retrospective detection of Ebola West Africa 2013 (months ahead) and COVID-19 Hubei pneumonia Nov 2019 (one month before official report). | **Foundational paper** establishing AI-EBS proof of concept | — |
| **Epidemic Information Extraction for Event-Based Surveillance using Large Language Models** (Consoli et al., JRC) | https://arxiv.org/pdf/2408.14277 | 2024 | European Commission JRC evaluated 8 LLMs and traditional NLP. GPT-4: 0.84 F1 (disease), 0.954 (country), 0.814 (date), 0.629 (cases). Open-source ensemble matched commercial at 1% cost. | **Most rigorous technical benchmark** for LLM epidemic IE on ~71,000 real surveillance documents | an important metric |
| **AI-driven epidemic intelligence: the future of outbreak detection and response** (Kaur & Butt) | https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2025.1645467 | 2025 | University of Waterloo & NRC Canada. Integrated framework combining LLMs, outbreak forecasting, ED optimization. Highlights PandemicLLM and SIR-INN. | **Forward-looking conceptual framework** | an important summary |
| **Artificial intelligence in public health: the potential of epidemic early warning systems** (Lim et al.) | https://doi.org/10.1177/03000605231159335 | 2023 | UNSW review of 8 early warning systems. Stress need for AI + NLP for unstructured data. Note human moderation still essential. | **Comprehensive systems review** | an important eight warning system review and comparison, including: ProMED-mail, HealthMap, Epidemic Intelligence from Open Sources, BlueDot, Metabiota, the Global Biosurveillance Portal, Epitweetr and EPIWATCH |
| **Editorial: Infectious Disease Surveillance Using AI** (Parums DV) | https://doi.org/10.12659/msm.941209 | 2023 | Editorial overview. WHO Hub (Berlin, 2021). CDC Center for Forecasting and Outbreak Analytics (2021). Federated learning. | **Institutional landscape overview** | no recent insights |
| **AI in health and medicine** (Rajpurkar et al., Nat Med) | https://doi.org/10.1038/s41591-021-01614-0 | 2022 | LLM advances (GPT-4) hold promise for surveillance. HealthMap COVID cluster alert Dec 30, 2019. Greece's Eva (RL at borders) — 1.25–1.45× asymptomatic detection. | **High-impact synthesis** | an important graph on challenges, progress, opportunities |
| 🆕 **A BEACON for Novel Disease Threats** (BEACON Team, *J Infect Dis*) | https://academic.oup.com/jid/article/233/2/e287/8407011 | 2026 | Boston University. First generative-AI native EBS platform. PandemIQ Llama (domain-adapted) powers multi-agent system. HealthMap feed (17 languages, hourly). Free + open-source. | **Landmark 2026 paper** — first peer-reviewed description of operational agentic LLM in EBS | a recent important implementation |
| 🆕 **AI Agents and Epidemic Intelligence on Respiratory Infectious Diseases: Quadripartite Framework** (Yang et al., JMIR) | https://www.jmir.org/2026/1/e86936 | 2026 | Conceptual framework adding 4th pillar: decision support via AI agents. Examples include RSV outbreak ICU optimization. | **Theoretical foundation** for agentic AI integration | mentioned above. important |
| 🆕 **Harnessing the power of artificial intelligence for disease-surveillance purposes** (Tornimbene et al., WHO PEII Innovation Forum) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11887143 | 2025 | 6th WHO Pandemic & Epidemic Intelligence Innovation Forum proceedings. Boston Children's, AI4PEP, MSF, Sydney perspectives. | **Multi-stakeholder governance synthesis** | https://global.health/ is a new website with limited and curated info for avian flu, and mpox |


---

## REFERENCE TABLE 2: Operational Surveillance Systems (Updated 2026)

| System | Organization/Origin | Year Launched | AI/Tech | Key Capability | Documented Early Detection |
|--------|---------------------|---------------|---------|----------------|---------------------------|
| **EPIWATCH** | UNSW Kirby Institute (Australia) | 2016 | BERT-based classification (88.2% accuracy), NLP entity recognition, ArcGIS location API | Open-access via epiwatch.org. 46-language coverage. Two AI sub-systems. Daily human-curated review. | Ebola West Africa 2013 (months ahead); COVID-19 Hubei Nov 2019 (one month ahead); cholera/botulism/rabies in Ukraine 2022; 110 syndromic outbreaks in India (2020–2022) |
| **EIOS** (Epidemic Intelligence from Open Sources) | WHO + European Commission JRC | 2017 | NLP recognition, article classification, priority algorithms | 40M+ news items, 12,000+ web sources. **🆕 110+ countries and 30+ organizations (2026)**, up from ~70 (2024). 34 African countries, 900+ trained users. | Africa: 81% events detected; 47.4% early sensitivity; harmonic mean 59.8%; 75.7% (2018) → 87.5% (2023) |
| **HealthMap** | Boston Children's Hospital | 2006 | Fisher-Robinson Bayesian filtering, text processing. **🆕 Now feeds BEACON** | ~80 alerts/day. **17-language** coverage (per BEACON publication). Hourly scrapes. Geospatial visualization. | Dec 30, 2019 COVID-19 "cluster of pneumonia of unknown cause" warning |
| **ProMED-mail** | International Society for Infectious Diseases | 1994 | Human-curated, expert moderators (not AI-based) | 66,000+ posts. Collaborates with AI systems. | First reports of SARS, Chikungunya, Ebola, Zika, MERS, COVID-19 |
| **BlueDot** | Canadian commercial | ~2014 | AI + human moderation, transport network modeling, multilingual, closed-source gov data | **Paywalled** — paying clients only. Identifies hotspots via clustering. | Early alert on COVID-19 emergence in Wuhan, late 2019 |
| **Metabiota** | Commercial (USA) | ~2008 | Heat maps, Pathogen Sentiment Index | 208 pathogens. Disease + economic impact. Insurance/travel industries. | N/A (risk modeling focus) |
| **CDC Global Biosurveillance Portal (GBSP)** | US CDC + Dept of Defense | ~2021 | AI-based predictive analysis | Near real-time sharing, mapping. Federal agency data. | N/A (info-sharing platform) |
| 🆕 **BEACON** (Biothreats Emergence, Analysis and Communications Network) | Boston University + Hariri Institute + HealthMap | **April 2025** | **PandemIQ Llama LLM (fine-tuned)** + multi-agent architecture | Open-source. Free. Generative AI for outbreak reports. Multi-source signals (HealthMap, SMEs, public health partners, user submissions). Source credibility, recency, severity assessment. | Active monitoring since 2025; partnerships with WHO EIOS, WOAH, CEPI, CDC CFA |

> 💭 **[KAI]:** _Add your note here..._

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 3: Agentic AI & Multi-Agent Systems (2024–2026)

| Title | Link | Year | Key Finding | Relevance | KAI Notes |
|-------|------|------|-------------|-----------|-----------|
| **ARIES: A Scalable Multi-Agent Orchestration Framework** (Wattamwar & Akwafuo) | https://arxiv.org/html/2601.01831 | **Jan 2026** | Cal State Fullerton. Hierarchical command structure with GPT models. Components: Flows, Crews, Agents, Process, Tasks. Configurable: Memory, LLMs, Knowledge, Reasoning, Training, Tools. Inspired by 90.2% zero-shot classification on COVID/Mpox. | **First comprehensive agentic framework** for epidemic intelligence | — |
| **EpiPlanAgent: Agentic Automated Epidemic Response Planning** | https://arxiv.org/pdf/2512.10313 | 2025 | Multi-agent for emergency response planning. LLMs generate/refine/validate plans. | **Closes gap between detection and response** | — |
| 🆕 **AI Agents and Epidemic Intelligence on Respiratory Infectious Diseases** (Yang et al.) | https://www.jmir.org/2026/1/e86936 | **2026** | Quadripartite framework. AI agents as "24/7 digital epidemiologists" for RSV/flu. ICU optimization examples. | **2026 paradigm shift** — AI agents as operational epidemiologists | — |
| **Viral Sentry AI (VirSentAI) - Zoonotic Surveillance & Drug Repurposing Agent** | https://www.biorxiv.org/content/10.64898/2025.12.29.684576.full.pdf | 2025 | Computational agents for zoonotic spillover from viral genomic data | **Specialized agentic system** for spillover | — |
| **Reinforcement Learning AI at Borders (Eva, Greece)** | Referenced in Rajpurkar et al. Nat Med 2022 | 2020–22 | RL screening detected 1.25–1.45× more asymptomatic travelers vs traditional metrics | **Real-world agentic AI deployment** for outbreak response | — |
| 🆕 **BEACON multi-agent architecture** (Bhadelia, Brownstein, Paschalidis et al.) | https://academic.oup.com/jid/article/233/2/e287/8407011 | **2026** | **PandemIQ Llama LLM powers multiple AI agents** with custom-engineered prompts incorporating SME decision-making. Iterative SME feedback loop fine-tunes LLM. | **Operational agentic LLM in EBS** — first peer-reviewed | — |
| **Agent-based simulation models for epidemic geospatial dynamics** | Referenced in Lim et al. 2023 | 2023 | Multi-agent simulations with synthetic populations | **Decision support agentic AI** for interventions | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 4: WHO EIOS & Global Deployment (Updated 2026)

| Title | Link | Year | Key Finding | Relevance | KAI Notes |
|-------|------|------|-------------|-----------|-----------|
| **The EIOS Initiative** (WHO) | https://www.who.int/initiatives/eios | 2024 | WHO Hub (Berlin, since Jan 2022). EIOS Strategy 2024–2026. | **Global standardization platform** | — |
| **Evaluation of EIOS in African region** (Impouma et al.) | https://doi.org/10.1186/s12889-025-21998-9 | 2025 | 47 countries (2018–2023). 81% events detected; sensitivity 47.4%; harmonic mean 59.8%. 75.7%→87.5%. Botswana, Eritrea, Sao Tome, Seychelles 100% early detection. 34 countries, 900+ users. | **Definitive regional effectiveness analysis** | — |
| **EBS in Republic of Korea** | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325167 | 2025 | KDCA integrated EIOS 2023. 16/20 signals via EIOS in 2-week sample. | **Asian national implementation** | — |
| **Evaluation framework for EIOS at Robert Koch Institute** | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12881845 | 2026 | RKI 2023 evaluation. +35% articles screened but 35-fold info increase (precision-recall trade-off). | **Operational performance assessment** | — |
| **Fifth EIOS Global Technical Meeting (Dakar 2024)** | https://pmc.ncbi.nlm.nih.gov/articles/PMC12442272 | 2025 | 200+ participants, 70 countries. | **Community of practice update** | — |
| **Epidemic Intelligence - PAHO/WHO** | https://www.paho.org/en/topics/epidemic-intelligence | 2024 | Americas: 2M+ pieces screened/year. 1,418 signals detected (2024). 30% of global events. | **Regional metrics** | — |
| 🆕 **WHO DG opening remarks, 158th Executive Board** (Feb 2026) | https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-158th-session-of-the-executive-board-2-february-2026 | **Feb 2026** | EIOS now supports **110+ countries and 30+ organizations**. GISRS processed 12M+ samples. PIP: 900M+ vaccine doses agreements. | **2026 expansion milestone** | — |
| 🆕 **WHO Hub Annual Update — Feb 2026** | https://pandemichub.who.int/news-room/news/item/26-02-2026-february-2026-update-from-the-who-hub-for-pandemic-and-epidemic-intelligence | **Feb 2026** | First-of-its-kind **Pandemic and Epidemic Intelligence Research Funding Tracker** (with Pandemic PACT). Maps 23 priority research areas. | **Transparency tool** for pandemic research funding | — |
| 🆕 **WHO Hub Annual Update — Mar 2026** | https://pandemichub.who.int/news-room/news/item/20-03-2026-march-2026-update-from-the-who-hub-for-pandemic-and-epidemic-intelligence | **Mar 2026** | 2025 Annual Report. Hub worked with **160+ Member States and 190+ partners**. | **Scale of WHO Hub operations** | — |
| 🆕 **WHO EMRO AI Community of Practice** | https://www.emro.who.int/media/news/who-regional-office-for-the-eastern-mediterranean-launches-ai-community-of-practice-for-disaster-and-emergency-response-surveillance.html | **Apr 2026** | EMRO + WHO Collaboratory. Part of **WHO AI Literacy Programme**. Curated training, peer learning, working groups. AIM Toolkit deployed in 20 countries. | **Regional capacity-building** | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 5: Country & Regional Case Studies

| Country/Region | System Used | Notable Finding | Significance | KAI Notes |
|----------------|-------------|-----------------|--------------|-----------|
| **Ukraine** (2022) | EPIWATCH | During Russian invasion, formal surveillance collapsed. Detected cholera, botulism, rabies. Ukrainian added Feb 2022 → 46-language coverage. | **Conflict-zone surveillance** | — |
| **India** (2020–2022) | EPIWATCH | 110 syndromic outbreaks (highest globally) — multilingual + media coverage | **Multilingual capacity** drives detection equity | — |
| **Greece** (2020+) | Eva (RL) | 1.25–1.45× more asymptomatic detected at borders | **First operational RL deployment** for border surveillance | — |
| **African Region** (34 countries) | EIOS | 81% detected. 4 countries (Botswana, Eritrea, Sao Tome, Seychelles) achieved 100% early detection. Central & West Africa highest performance post-Ebola. | **High-impact LMIC deployment** | — |
| **Australia** (2016+) | EPIWATCH | MRFF/NHMRC + Balvi Filantropic funded. Open-access platform. | **Sustainable open-access model** | — |
| **United Kingdom** (2021) | Global Pandemic Radar | Genomic surveillance | **Government-led initiative** | — |
| **United States** (2021+) | CDC GBSP + CFA + 🆕 BEACON partnerships (2025+) | DoD + federal agency integration. Now also CDC CFA partner with BEACON. | **National strategic infrastructure** | — |
| **South Korea** (2023+) | EIOS via KDCA | Daily dashboard, routine SOP integration | **East Asian institutional adoption** | — |
| 🆕 **WHO Eastern Mediterranean** (2026) | AIM Toolkit + AI Community of Practice | 20 countries trained in AIM Toolkit. Curated AI training modules. | **Conflict-prone region capacity building** | — |
| 🆕 **China** (2025+) | ChatGPT-assisted deep learning | Guangxi Medical University used ChatGPT to develop 5 DL architectures (LSTM, N-BEATS, transformer, TFT, TiDE) for ILI prediction. | **LLM as research accelerator** for traditional epi modeling | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 6: Outbreaks of Unknown Cause & Diagnostic Dependence

| Title | Link | Year | Key Finding | Relevance | KAI Notes |
|-------|------|------|-------------|-----------|-----------|
| **Global Epidemiology of Outbreaks of Unknown Cause Identified by OSINT, 2020–2022** (Honeyman et al., Emerg Infect Dis) | https://doi.org/10.3201/eid3102.240533 | 2025 | EPIWATCH identified 310 outbreaks of unknown cause: 75,968 cases, 4,235 deaths. Only **12.9% of human outbreaks** subsequently had cause identified — especially LMICs. India 110 syndromic outbreaks. | **Highlights diagnostic dependence** of event verification | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 7: Social Media & Misinformation Surveillance

| Title | Link | Year | Key Finding | Relevance | KAI Notes |
|-------|------|------|-------------|-----------|-----------|
| **Public sentiment on monkeypox: 352,182 Twitter posts** (Ng et al.) | https://doi.org/10.1016/j.puhe.2022.09.008 | 2022 | BERT + BERTopic. Identified LGBTQ+ stigmatization, political mistrust, misinformation. | **AI's dual role**: surveillance AND social response monitoring | — |
| **A Twitter dataset for Monkeypox** (Nia et al.) | https://doi.org/10.1016/j.dib.2023.109118 | 2023 | Twitter dataset infrastructure | **Data resource** for replicable surveillance | — |
| **Leveraging LLMs for Infectious Disease Surveillance from Self-Reporting Tweets (Covlab)** | https://www.jmir.org/2025/1/e63190 | 2025 | 7.3M COVID tweets (2020–2024). 262,278 self-reported cases. 7.63 days ahead of official. Identified non-CDC symptoms. | **Quantitative pre-symptomatic signal** | — |
| 🆕 **Use of LLMs to Assess Epidemics from Tweets (GPT-3.5/GPT-4 on conjunctivitis)** | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10943433 | 2024 | 12,194 conjunctivitis tweets, 9 locations, multiple languages. GPT-3.5 r=0.60 with human raters; GPT-4 higher. Validates LLMs for **probabilistic epidemic assessment** from social media. | **LLM probabilistic signal scoring** | — |
| 🆕 **Generative AI for COVID Prediction comparative study** (Liang et al.) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12480999 | 2025 | Compared **ChatGPT, DeepSeek, Kimi** against statistical/ML models for COVID prediction in US, UK, Germany, Russia. Demonstrates **non-OpenAI LLMs** (DeepSeek, Kimi) competitive in surveillance. | **Multi-LLM benchmark** beyond GPT | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 8: Current Challenges & Limitations (Updated)

| Challenge | Source | Year | Specific Finding | KAI Notes |
|-----------|--------|------|------------------|-----------|
| **Data Quality & Volume** | MacIntyre et al. 2022; Lim et al. 2023 | 2022–23 | "Unmanageable volumes of data." False positive over-catch with high sensitivity. | — |
| **Algorithmic Bias & Representativeness** | Rajpurkar 2022 (Nat Med); Honeyman 2025 | 2022–25 | US COVID-19 mortality: **60% underreporting of Black/Hispanic deaths**. Anglocentric bias partly offset by EPIWATCH's 46 languages. | — |
| **Geopolitical & Internet Access Bias** | Impouma et al. 2025 | 2025 | Internet penetration ↔ detection rates. | — |
| **Slow Public Health Integration** | Lim et al. 2023 | 2023 | Public health "slower to embrace AI than clinical counterparts." Most systems "niche tools." | — |
| **Privacy & Ethical Concerns** | Parums 2023; Rajpurkar 2022 | 2022–23 | Privacy, discrimination, access to care concerns. **Federated learning** proposed. | — |
| **Misinformation & Stigma Amplification** | Ng 2022; Nia 2023 | 2022–23 | AI must detect AND counter misinformation. Avoid amplifying LGBTQ+ stigmatization (MPX). | — |
| **Validation & Generalizability** | Parums 2023; Rajpurkar 2022 | 2022–23 | "Never completely accurate." Constant recalibration. | — |
| **Diagnostic Dependence** | Honeyman 2025 | 2025 | Only **12.9% of unknown human outbreaks** have cause identified. | — |
| **LLM Hallucinations & Technical Limits** | Rajpurkar 2022; Frontiers 2025 | 2022–25 | 2023 ChatGPT-4 example: false "yes" to COVID vaccine infertility question. | — |
| **Black Box Problem** | Multiple reviews | 2023–25 | Deep learning lacks interpretability. Audit limitations. | — |
| **System Interoperability** | Kaur & Butt 2025 | 2025 | Healthcare DBs, surveillance platforms, AI models in silos. | — |
| **LMIC Infrastructure Gaps** | Multiple | 2024–25 | GPT-4 API costs ($150–200 per 1,000 docs) prohibitive at scale. | — |
| **Workforce Capacity** | WHO EIOS GTM 2024 | 2024 | Epidemiologists lack ML training; data scientists lack epi expertise. | — |
| 🆕 **AI-generated misinformation indistinguishable from human content** | Multiple 2026 sources | **2026** | Traditional linguistic red flags (grammar, awkward phrasing) no longer detect fraudulent reports. Direct surveillance threat: AI-fabricated outbreak reports could enter EBS pipelines. | — |
| 🆕 **Black box critique sharpens** (Koopmans 2026) | https://www.medscape.com/viewarticle/could-artificial-intelligence-help-predict-next-pandemic-2026a10001a7 | **2026** | "AI tools should be evaluated with the same rigor applied to new diagnostics." — **Calls for diagnostic-grade validation** for AI surveillance | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 9: Future Directions & Emerging Technologies (Updated)

| Direction | Source | Timeline | Description | KAI Notes |
|-----------|--------|----------|-------------|-----------|
| **Multimodal LLMs (PandemicLLM)** | Kaur & Butt 2025 | 2025–26 | Text + genomic + policy + behavioral + climate. Outperforms time-series by 15–30%. | — |
| **Physics-Informed Neural Networks (SIR-INN)** | Rama et al. 2025 | 2025–27 | Real-time flu data into modified SIR. Interpretable + predictive. | — |
| **Agentic AI / Autonomous Agents** | Wattamwar 2026; EpiPlanAgent 2025; Yang 2026; BEACON | **2025–28** | **🆕 OPERATIONAL** (BEACON, ARIES 2026). Multi-agent "24/7 digital epidemiologists." | — |
| **Wearable Biosignals** | Rajpurkar 2022 | 2025–28 | Smartwatch for pre-symptomatic detection. | — |
| **Wastewater Surveillance Integration** | Multiple | Ongoing | Genomic + environmental + LLM synthesis. | — |
| **Satellite Imagery for Vector Habitat** | Climate-AI reviews | 2026+ | Geospatial AI for mosquitoes, ticks. | — |
| **Federated Learning** | Parums 2023 | 2026–27 | Distributed ML preserving data sovereignty. LMIC participation. | — |
| **Explainable AI (XAI)** | Frontiers 2025 | 2025–26 | Attention visualization, counterfactuals, LIME. | — |
| **Real-Time Healthcare Resource Optimization** | Kaur & Butt 2025; Yang 2026 | 2026+ | AI with ICU, vaccine, ED surge planning. | — |
| **Quantum Computing for Surveillance** | Parums 2023 | Long-term | Theoretical massively parallel signal processing. | — |
| **Biosensors & Augmented Intelligence** | Parums 2023 | 2026–28 | Point-of-care biosensors feeding AI. | — |
| 🆕 **WEF Pandemic Preparedness Engine (PPX)** | WEF Jan 2026 | **2026+** | WEF + CEPI. End-to-end R&D platform. Agentic AI integration. | — |
| 🆕 **Global Pathogen Analysis Platform (GPAP)** | WEF Jan 2026 | **2026+** | World's first globally accessible AI platform for **One Health** pathogen data (human, animal, plant, environmental). | — |
| 🆕 **WHO All-Hazards Information Management (AIM) Toolkit** | WHO 2025–2026 | **2025–26** | AI-powered emergency info management. 20 countries trained. | — |
| 🆕 **WHO AI Literacy Programme** | WHO EMRO 2026 | **2026+** | Multi-regional capacity building. Communities of Practice. | — |
| 🆕 **Domain-adapted LLMs (PandemIQ Llama model)** | BEACON 2025 | **2025+** | Fine-tuned foundational LLMs for surveillance domain. Sets template for future systems. | — |
| **TEPHINET Field Epi Training** | MacIntyre 2022 | Ongoing | Digital surveillance in curriculum. | — |
| **Rockefeller Pandemic Prevention Institute** | Parums 2023 | Ongoing | Collaborative network. | — |

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 10: Key Institutions & Governance (Updated 2026)

| Institution | Established | Location | Role |
|-------------|-------------|----------|------|
| **WHO Hub for Pandemic and Epidemic Intelligence** | 2021 | Berlin | EIOS leadership, capacity building. 🆕 160+ Member States, 190+ partners (2025). Head: Dr Oliver Morgan. |
| **CDC Center for Forecasting and Outbreak Analytics (CFA)** | 2021 | Atlanta | AI-enhanced modeling. Now BEACON partner. |
| **CDC Global Biosurveillance Portal (GBSP)** | ~2021 | USA | Web-based, DoD + agency data, AI predictive |
| **ECDC** | 2005 | Stockholm | Epitweetr; EU coordination |
| **European Commission Joint Research Centre (JRC)** | 1957 | Ispra | EIOS co-developer; LLM research |
| **WHO GISRS** | 1952 | Geneva | Influenza network. 🆕 12M+ samples processed (2025). |
| **World Bank AI for Epidemic Preparedness (AI4EP)** | Recent | Global | LMIC AI capacity funding |
| **Global South AI for Pandemic & Epidemic Preparedness (AI4PEP)** | Recent | Global South | Equity-focused LMIC capacity |
| **Rockefeller Pandemic Prevention Institute** | 2021 | USA + global | Collaborative network |
| **UNSW Kirby Institute (EPIWATCH)** | 2016 | Sydney | EPIWATCH operations |
| **Boston Children's Hospital (HealthMap)** | 2006 | Boston | Longest-running automated EBS |
| 🆕 **Boston University Center on Emerging Infectious Diseases (CEID)** | ~2022 | Boston | **BEACON home**. Director: Dr Nahid Bhadelia |
| 🆕 **Hariri Institute for Computing and Data Sciences (BU)** | Existing; BEACON partner 2025 | Boston | **PandemIQ Llama development**. Director: Dr Yannis Paschalidis |
| **International Society for Infectious Diseases (ISID, ProMED)** | 1986/1994 | Global | Human-moderated reporting |
| **TEPHINET** | 1997 | Global | Field epi training; digital surveillance curriculum |
| 🆕 **WEF + CEPI Pandemic Preparedness Engine (PPX)** | Jan 2026 announcement | Global | End-to-end R&D platform |
| 🆕 **Global Pathogen Analysis Platform (GPAP)** | Jan 2026 | Global | First One Health AI platform |
| 🆕 **WHO Eastern Mediterranean AI Community of Practice** | April 2026 | Cairo | Regional capacity, training |
| 🆕 **Pandemic PACT programme** (with WHO Hub) | 2026 | Global | Research funding tracker |

> 💭 **[KAI]:** _Add your note here..._

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## REFERENCE TABLE 11: Technical Performance Benchmarks (Updated)

| Metric | System/Study | Value | Notes |
|--------|--------------|-------|-------|
| **EPIWATCH classification accuracy** | UNSW, BERT-based | 88.2% | NLP/NER + classification |
| **EIOS African detection rate** | Impouma 2025 | 81% overall; 75.7%→87.5% | Public health events |
| **EIOS Africa sensitivity (early)** | Impouma 2025 | 47.4% | Before official |
| **EIOS Africa harmonic mean** | Impouma 2025 | 59.8% | |
| **EIOS Africa 100% early detection countries** | Impouma 2025 | Botswana, Eritrea, Sao Tome, Seychelles | 4 of 34 |
| **HealthMap daily alerts** | Lim 2023; BEACON 2026 | ~80; **17 languages (2026)** | Was 9+ languages in 2023, expanded |
| **EIOS news items** | Lim 2023 | 40M+ | 12,000+ web sources |
| **EPIWATCH languages** | MacIntyre 2022; Honeyman 2025 | 46 | Ukrainian added Feb 2022 |
| **LLM Disease F1 (GPT-4)** | Consoli 2024 | 0.84 | vs 0.705 baseline |
| **LLM Country F1 (GPT-4)** | Consoli 2024 | 0.954 | |
| **LLM Date F1 (Zephyr-7b)** | Consoli 2024 | 0.858 | Open-source matched commercial |
| **LLM Case count F1 (GPT-4-FewShots)** | Consoli 2024 | 0.653 | Remains challenging |
| **Cost per 1K docs (GPT-4)** | Consoli 2024 | $150–200 | Commercial API |
| **Cost per 1K docs (Llama-2/Mistral)** | Consoli 2024 | $5–10 | On-prem GPU |
| **Eva (Greece) asymptomatic detection** | Rajpurkar 2022 | 1.25–1.45× | vs traditional metrics |
| **Twitter prediction lead time (Covlab)** | JMIR 2025 | 7.63 days | Ahead of official |
| **Unknown outbreaks with cause identified** | Honeyman 2025 | 12.9% (human) | Diagnostic dependence |
| **EIOS African trained users (2023)** | Impouma 2025 | 900+ | 34 countries |
| **EPIWATCH unknown-cause outbreaks (2020–2022)** | Honeyman 2025 | 310 outbreaks; 75,968 cases; 4,235 deaths | |
| 🆕 **EIOS countries supported (2026)** | WHO DG Feb 2026 | **110+ countries, 30+ organizations** | Up from ~70 in 2024 |
| 🆕 **WHO Hub partner countries (2025)** | WHO Hub Mar 2026 | **160+ Member States, 190+ partners** | |
| 🆕 **AIM Toolkit countries trained** | WHO EMRO 2026 | 20 countries | |
| 🆕 **GISRS samples processed (2025)** | WHO DG 2026 | **12 million+** | |
| 🆕 **PIP vaccine doses agreements** | WHO DG 2026 | **900 million+** | Pandemic influenza preparedness |
| 🆕 **BEACON funding** | BEACON 2026 | **$6 million** | NSF, Gates Foundation, BU, private donors |
| 🆕 **BEACON languages (via HealthMap)** | BEACON 2026 | **17 languages** | Hourly scrapes |
| 🆕 **ARIES zero-shot classification precision** | Wattamwar 2026 | 90.2% | On COVID/Mpox datasets |
| 🆕 **GPT-3.5 correlation with human raters (conjunctivitis)** | PMC10943433 | r=0.60 | GPT-4 higher |

> 💭 **[KAI]:** _Add your note here..._

> 🧠 **[KAI–SYNTHESIS]:** _Section overall takeaway..._

---

## SYNTHESIS TABLE: Development State by Component (2022–2026)

| Component | 2022 | 2024 | **2026** | Maturity |
|-----------|------|------|----------|----------|
| **NLP/NER for EBS** | Operational | Mature | Mature, multilingual standard | **MATURE** |
| **LLM Information Extraction** | Experimental | Operational | **Domain-adapted LLMs operational** (PandemIQ Llama) | **MATURE** |
| **BERT/Transformer Classification** | EPIWATCH 88.2% | Widespread | Standard baseline | **MATURE** |
| **Agentic AI Systems** | Conceptual | First frameworks | **🆕 OPERATIONAL** (BEACON, ARIES, EpiPlanAgent) | **OPERATIONAL** |
| **Generative AI for Reports** | N/A | Emerging | **🆕 Operational** (BEACON PandemIQ Llama) | **EMERGING** |
| **Multimodal Integration** | Limited | Hybrid prototypes | **🆕 One Health platforms** (GPAP) | **EARLY-EMERGING** |
| **Physics-Informed Models** | Research | SIR-INN prototypes | Integration with LLM forecasting | **EMERGING** |
| **Explainable AI (XAI)** | Limited | Active research | Regulatory requirement; 2026 Koopmans calls for "diagnostic-grade validation" | **DEVELOPING** |
| **Global EIOS Deployment** | 30–40 countries | ~70 countries | **🆕 110+ countries, 30+ organizations** | **EXPANDED** |
| **Social Media Surveillance** | BERT operational | LLM-enhanced | Multi-LLM comparative benchmarking (ChatGPT, DeepSeek, Kimi) | **MATURE** |
| **Wearable Biosignals** | Pilots | Growing | Operational pre-symptomatic | **EARLY** |
| **Wastewater + AI** | Operational COVID | Multi-pathogen | Routine EBS integration | **MATURING** |
| **Reinforcement Learning** | Greece Eva | Expanded | Integrated outbreak management | **EMERGING** |
| **LMIC Access** | Concentrated HIC | Widening | **🆕 WHO AI Literacy + AIM Toolkit + AI4PEP** | **IMPROVING** |
| **Federated Learning** | Theoretical | Early pilots | Federated learning emerging | **EMERGING** |
| **Workforce Training** | Limited digital | Expanding | **🆕 WHO AI Literacy Programme; WHO Hub free courses** | **EXPANDING** |
| 🆕 **One Health AI Platforms** | N/A | N/A | **2026: GPAP launched** | **NEW** |
| 🆕 **AI-Generated Misinformation Detection** | Limited concern | Growing | **🆕 Critical 2026 challenge** | **CRITICAL GAP** |
| 🆕 **Research Funding Transparency** | N/A | N/A | **2026: WHO Pandemic Intelligence Funding Tracker** | **NEW** |

> 💭 **[KAI]:** _Add your note here..._

---

## KEY THEMATIC INSIGHTS (Updated for 2026)

### Insight 1: Conflict & Crisis as Stress Tests
Ukraine 2022 demonstrated AI-EBS as **resilience tool** when traditional surveillance collapses. EPIWATCH detected cholera, botulism, rabies. 2026 WHO EMRO AI Community of Practice formalizes this with explicit disaster/emergency surveillance focus.

> 💭 **[KAI]:** _Add your note here..._

### Insight 2: The Misinformation Dimension — Now a Critical Challenge
- **2022**: AI used to surveil misinformation (Ng et al. monkeypox)
- **2026**: AI-generated content indistinguishable from human → AI **becomes the source of misinformation it should detect**
- New verification frameworks needed

> 💭 **[KAI]:** _Add your note here..._

### Insight 3: Diagnostic Dependence is a Bottleneck
Only **12.9% of unknown human outbreaks ever have cause identified**. AI detection ≠ actionable intelligence without laboratory infrastructure. **Investment must be parallel.**

> 💭 **[KAI]:** _Add your note here..._

### Insight 4: Open Source vs. Commercial Divide Resolved Slightly in 2026
- 2024: EPIWATCH (free) vs BlueDot (paywalled) tension
- 2026: **BEACON launches as open-source generative-AI native platform** with $6M public/foundation funding. WHO embraces open-source ethos.
- The "global public good" framing wins at WEF 2026 (PPX, GPAP).

> 💭 **[KAI]:** _Add your note here..._

### Insight 5: Language Equity is Detection Equity
EPIWATCH 46 languages; BEACON via HealthMap 17 languages. Multilingual capability fundamental for LMIC outbreak detection.

> 💭 **[KAI]:** _Add your note here..._

### Insight 6: From BERT to Domain-Adapted Generative LLMs (2024 → 2026)
- 2024: BERT-based classification mature (EPIWATCH 88.2%)
- 2026: **Domain-adapted generative LLMs** (PandemIQ Llama) operational
- Shift from "classify articles" → "generate structured reports + assess credibility + draft analyses"

> 💭 **[KAI]:** _Add your note here..._

### Insight 7: Reinforcement Learning is Already Operational
Greece's Eva (1.25–1.45× asymptomatic improvement) — autonomous decision-support agents are saving lives, not future tech.

> 💭 **[KAI]:** _Add your note here..._

### 🆕 Insight 8: One Health AI Goes Operational (2026)
- GPAP (WEF + CEPI) = world's first AI platform for human + animal + plant + environmental pathogen data
- Reflects post-COVID consensus that zoonotic spillover monitoring is foundational

> 💭 **[KAI]:** _Add your note here..._

### 🆕 Insight 9: WHO AI Literacy Mainstreaming (2026)
- WHO AI Literacy Programme
- AIM Toolkit deployed in 20 countries
- Eastern Mediterranean Community of Practice (April 2026)
- Reflects shift from "experimental AI" → "institutional standard"

> 💭 **[KAI]:** _Add your note here..._

### 🆕 Insight 10: Research Funding Transparency Emerges (2026)
- WHO Pandemic and Epidemic Intelligence Research Funding Tracker
- First-of-its-kind tool mapping 23 priority research areas globally
- Enables strategic alignment, gap identification

> 💭 **[KAI]:** _Add your note here..._

### 🆕 Insight 11: LLM Diversification Beyond OpenAI
- 2024 benchmarks: GPT-4, Llama-2, Mistral, Zephyr
- 2025+ comparative studies: ChatGPT, **DeepSeek, Kimi** (Chinese models) competitive
- Geographic diversification of LLM ecosystem has implications for global health AI sovereignty

> 💭 **[KAI]:** _Add your note here..._

---

## CRITICAL UNKNOWNS & RESEARCH GAPS (Updated 2026)

1. **Real-world ROI**: Does AI early warning → faster response and lower fatality? Prospective studies needed.
2. **LMIC generalization**: How do LLMs perform in Southeast Asia, sub-Saharan Africa?
3. **Interoperability standards**: Can EIOS + HealthMap + BlueDot + **BEACON** + national systems exchange signals real-time?
4. **Agentic reliability**: Do multi-agent systems reduce hallucination vs. single LLMs? **BEACON's iterative SME feedback loop is testing this in production**.
5. **Ethical governance**: Balance global benefit with sovereignty and privacy.
6. **Diagnostic infrastructure gap**: 12.9% identification rate in LMICs.
7. **Misinformation containment**: Can AI counter AI-generated misinformation?
8. **Conflict-zone surveillance**: How to maintain AI-EBS in emergencies?
9. **Wearable biosignal specificity threshold**: When are smartwatch signals actionable?
10. **Federated learning at scale**: Operational readiness timeline?
11. 🆕 **PandemIQ Llama generalizability**: Does the BEACON model approach generalize to other domains/regions?
12. 🆕 **AI-AI verification**: When AI-generated reports enter EBS, how can other AI systems detect/verify them?
13. 🆕 **GPAP One Health integration**: Will the platform achieve animal + plant + environment data parity with human data?

> 💭 **[KAI]:** _Add your note here..._

---

## RECOMMENDED ACTIONS BY STAKEHOLDER (Updated 2026)

### For Public Health Organizations
1. **Invest in EIOS and regional variants** (110+ countries already; aim for 100% coverage by 2030)
2. **Pilot BEACON integration** alongside EIOS for redundancy and generative AI capabilities
3. **Establish AI validation units** — Koopmans 2026 framework
4. **Develop hybrid workflows** — AI + human epi
5. **Prioritize multilingual evaluation**
6. **Build conflict-resilient surveillance** — embed AI-EBS in emergency plans (WHO AIM Toolkit)
7. **Integrate misinformation monitoring**
8. 🆕 **Adopt WHO AI Literacy Programme curriculum**
9. 🆕 **Build provenance-tracking** for AI-generated content in surveillance pipelines

> 💭 **[KAI]:** _Add your note here..._

### For Researchers
1. **Standardized evaluation protocols** — diagnostic-grade rigor (Koopmans 2026)
2. **Release open-source pipelines** (BEACON precedent)
3. **Investigate agentic frameworks**
4. **Conduct prospective trials** linking detection → response → outcomes
5. **Study language equity systematically**
6. 🆕 **Benchmark non-Western LLMs** (DeepSeek, Kimi) for sovereignty considerations
7. 🆕 **Develop AI-AI verification methods** (cryptographic, multi-source corroboration)
8. 🆕 **Apply to WHO Pandemic Intelligence Research Funding Tracker** to identify funding gaps

> 💭 **[KAI]:** _Add your note here..._

### For Funders & Governments
1. **Support WHO Hub** (now 160+ Member States, 190+ partners)
2. **Fund interdisciplinary teams**
3. **Establish governance frameworks**
4. **Incentivize data sharing**
5. **Invest in LMIC diagnostic infrastructure**
6. **Mandate language equity**
7. 🆕 **Support BEACON-model open-source AI platforms** as global public goods
8. 🆕 **Fund One Health AI integration** (GPAP-like platforms)
9. 🆕 **Underwrite WHO AI Literacy Programme expansion**

> 💭 **[KAI]:** _Add your note here..._

### For Field Epidemiologists (Practical Skills)
1. **Develop AI literacy** (WHO AI Literacy Programme available)
2. **Engage with TEPHINET digital surveillance modules**
3. **Practice critical appraisal of AI signals**
4. **Build interdisciplinary collaboration skills**
5. 🆕 **Become BEACON user** (free, open-source — sign up at beaconbio.org)
6. 🆕 **Take WHO Foundations of Public Health Intelligence course** (free, online, self-paced — 2026)
7. 🆕 **Understand domain-adapted vs general LLM distinction**

> 💭 **[KAI]:** _Add your note here..._

---

## COMPREHENSIVE BIBLIOGRAPHY (Updated 2026)

### Primary Literature (2022–2026)

1. **MacIntyre CR, Lim S, Quigley A.** Preventing the next pandemic: Use of artificial intelligence for epidemic monitoring and alerts. *Cell Rep Med.* 2022;3(12):100867. DOI: 10.1016/j.xcrm.2022.100867
2. **Lim S, et al.** Artificial intelligence in public health: the potential of epidemic early warning systems. *J Int Med Res.* 2023;51(3):03000605231159335.
3. **Parums DV.** Editorial: Infectious Disease Surveillance Using AI. *Med Sci Monit.* 2023;29:e941209.
4. **Honeyman D, et al.** Global Epidemiology of Outbreaks of Unknown Cause Identified by Open-Source Intelligence, 2020–2022. *Emerg Infect Dis.* 2025;31(2). DOI: 10.3201/eid3102.240533
5. **Ng QX, Yau CE, Lim YL, et al.** Public sentiment on the global outbreak of monkeypox. *Public Health.* 2022;213:1-4.
6. **Rajpurkar P, Chen E, Banerjee O, Topol EJ.** AI in health and medicine. *Nat Med.* 2022;28:31-38.
7. **Nia Z, Bragazzi N, Kong J, Wu J.** A Twitter dataset for Monkeypox, May 2022. *Data Brief.* 2023;48:109118.
8. **Impouma B, et al.** Evaluation of the EIOS system for the early detection of outbreaks in the African region. *BMC Public Health.* 2025;25:21998.
9. **Brownstein JS, Rader B, Astley CM, Tian H.** Advances in Artificial Intelligence for Infectious-Disease Surveillance. *N Engl J Med.* 2023;388(17):1597-1607.
10. **Consoli S, Markov P, Stilianakis NI, et al.** Epidemic Information Extraction for Event-Based Surveillance using Large Language Models. *Proc 9th Int Congr ICT.* 2024.
11. **Kaur J, Butt ZA.** AI-driven epidemic intelligence: the future of outbreak detection and response. *Front Artif Intell.* 2025;8:1645467.
12. **Villanueva-Miranda L, Xiao Y, Xie X.** AI in early warning systems for infectious disease surveillance: a systematic review. *Front Public Health.* 2025;13:1609615.
13. **Wattamwar A, Akwafuo S.** ARIES: A Scalable Multi-Agent Orchestration Framework. *arXiv* 2601.01831. **2026**.
14. **Martín-Sánchez M, et al.** Design and implementation of an evaluation framework for the EIOS system at RKI, Germany, 2023. *Eurosurveillance.* 2026;31(5):2500363.
15. **Tornimbene B, Leiva Rioja ZB, Brownstein J, et al.** Harnessing the power of artificial intelligence for disease-surveillance purposes. (WHO PEII Innovation Forum). 2025. DOI: 10.1186/s12919-025-00320-w
16. 🆕 **BEACON Team (Bhadelia N, Brownstein J, Paschalidis Y, et al.).** A BEACON for Novel Disease Threats: Leveraging AI for Informal Event-Based Outbreak Surveillance. *J Infect Dis.* **2026**;233(2):e287. DOI: 10.1093/infdis/jiaf642
17. 🆕 **Yang L, Shan L, Cao X, et al.** AI Agents and Epidemic Intelligence on Respiratory Infectious Diseases: Toward a Conceptual Framework Integrating Decision Support. *J Med Internet Res.* **2026**;28:e86936. DOI: 10.2196/86936
18. 🆕 **Liang Z, Liang G, Kuang Y, Li Z.** Application and Comparative Study of Generative AI for Epidemic Prediction of Coronavirus Disease. *Cureus.* 2025. DOI: 10.7759/cureus.91318
19. 🆕 **Huang W, et al.** ChatGPT-Assisted Deep Learning Models for Influenza-Like Illness Prediction in Mainland China. *JMIR.* 2025. DOI: 10.2196/74423
20. **WHO Director-General.** Opening remarks at the 158th session of the Executive Board, 2 February 2026.
21. **WHO Hub for Pandemic and Epidemic Intelligence.** February 2026 Update; March 2026 Update.
22. **WHO Eastern Mediterranean Regional Office.** Launch of AI Community of Practice for Disaster and Emergency Response Surveillance. April 16, 2026.
23. **World Economic Forum.** How AI reshapes global preparedness for infectious disease. January 23, 2026.
24. **Koopmans M (cited in Medscape).** Could Artificial Intelligence Help Predict the Next Pandemic? January 14, 2026.

### Key URLs

- WHO EIOS: https://www.who.int/initiatives/eios
- WHO Hub for Pandemic and Epidemic Intelligence: https://pandemichub.who.int
- 🆕 **BEACON**: https://beaconbio.org
- EPIWATCH: https://www.epiwatch.org
- HealthMap: https://www.healthmap.org
- ProMED-mail: https://promedmail.org
- PAHO Epidemic Intelligence: https://www.paho.org/en/topics/epidemic-intelligence
- 🆕 **WHO AI Literacy Programme** (via WHO Collaboratory)
- 🆕 **WHO Pandemic and Epidemic Intelligence Research Funding Tracker** (via Pandemic PACT)

---

## CONCLUSION

The period **2022–May 2026 marks a decisive transition** in epidemic intelligence:

**Key 2026 Milestones:**
- **BEACON launches** (April 2025) — first generative-AI native EBS platform, peer-reviewed (Feb 2026)
- **EIOS expands** to 110+ countries, 30+ organizations
- **WHO AI Literacy Programme** mainstreams AI capacity
- **WEF announces PPX and GPAP** — global public goods for pandemic preparedness
- **AI agents operational** (BEACON, ARIES) — no longer "future"
- **One Health AI** operationalized (GPAP)
- **Domain-adapted LLMs** (PandemIQ Llama) replace generic models

**Persistent and new challenges:**
- Diagnostic dependence gap (12.9%)
- AI-generated misinformation indistinguishable from human content
- Need for "diagnostic-grade" validation of AI tools (Koopmans 2026)
- Equitable LMIC access despite progress

**Success depends on**:
1. WHO-led standardization (EIOS, AIM Toolkit, AI Literacy)
2. Democratization (BEACON model, GPAP as public good)
3. Diagnostic-grade validation (Koopmans framework)
4. Governance balancing innovation with accountability
5. Multilingual, multimodal, One Health integration
6. AI-AI verification frameworks for fabricated content

> 🧠 **[KAI–OVERALL SYNTHESIS]:** _Your overall conclusion here..._

**The question is no longer *whether* AI transforms epidemic surveillance — clearly it has. The 2026 question is *how fast can the global health community ensure that transformation benefits all nations equitably and counters emerging threats including AI-fabricated misinformation, while maintaining diagnostic-grade rigor.***

---

## CHANGE LOG

| Version | Date | Changes |
|---------|------|---------|
| 1.0 | May 2026 | Initial scoping analysis |
| 2.0 | May 2026 | Reference table format added |
| 3.0 | May 2026 | SciBot integration (Ukraine, India, Greece, Metabiota, GBSP, monkeypox, diagnostic dependence) |
| 4.0 | **May 13, 2026** | **2026 additions**: BEACON, WHO EIOS expansion to 110+ countries, AIM Toolkit, AI Community of Practice, Research Funding Tracker, PPX/GPAP (WEF), Yang 2026 quadripartite framework, ARIES formalization, PandemIQ Llama, Koopmans critique, AI-generated misinformation challenge, LLM diversification (DeepSeek, Kimi), ChatGPT-assisted DL workflows. **Personal annotation system added.** |

---

**Document End** | Version 4.0 | Filename: `LLM_AI_Surveillance_Scoping_Analysis_v4_2026.md`
